Drug Dosing for Older Heart Patients Should Differ
Older heart patients present unique challenges for determining the optimal dosages of medications, so a new study from researchers at Duke Medicine offers some rare clarity about the use of drugs that are used to treat patients with heart attacks.
Aug. 16, 2013
Re-Analysis of Diabetes Drug Finds No Higher Heart Attack Risk
A re-analysis of the data from a pivotal study of rosiglitazone found no increased risk of cardiovascular events associated with the controversial diabetes drug, according to researchers at the Duke Clinical Research Institute (DCRI).
June 6, 2013
Symptoms and care of irregular heartbeats differ by gender
Women with atrial fibrilation have more symptoms and lower quality of life than men with the same heart condition, according to an analysis of patients in a large national registry compiled by the Duke Clinical Research Institute.
Mar. 11, 2013
Newest Screen For Newborns Will Indicate Heart Problems
About one in every 120 babies are born with congenital heart disease (CHD), of which about 25 percent is critical, requiring special care early in life. CHD is responsible for more deaths in the first year of life than any other birth defect, but often outcomes can be improved with early detection.
Aug. 22, 2011